PERSANTINE Side Effects

6639024-2 | Pleural Effusion, Renal Failure Acute
on Mar 11, 2010 Male patient from , 62 years of age, weighting 198.4 lb, was diagnosed with thrombosis prophylaxis, polycythaemia vera and was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion, renal failure acute. Persantine dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LOW MOLECULAR WEIGHT HEPARIN (View Low-molecular Weight Heparin Review and Low-molecular Weight Heparin Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ).

6517877-6 | Dry Mouth, Nasal Dryness, Pruritus, Tendonitis
Patient was taking Persantine (View Usage). Patient had the following side effects: dry mouth, nasal dryness, pruritus, tendonitis on Dec 19, 2009 from Additional patient health information: Male patient , 59 years of age, was diagnosed with cardiovascular event prophylaxis, rhabdomyolysis and. Persantine dosage: 75 Mg. During the same period patient was treated with RIVOTRIL (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

6508053-1 | Ageusia
Adverse event was reported on Dec 10, 2009 by a Male patient taking Persantine (View Usage) (Dosage: ) . Location: , 77 years of age, weighting 180.1 lb, After Persantine was administered, patient had the following side effects: ageusia. During the same period patient was treated with COLD REMEDY ORAL MIST (View Cold Remedy Oral Mist Review and Cold Remedy Oral Mist Label ), MEVACOR (View Mevacor Review and Mevacor Label ), ZETIA (View Zetia Review and Zetia Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), ZINC (75 Mg) (View Zinc Review and Zinc Label ).

6308363-7 | Atrial Fibrillation, Cardiac Failure, Chest Discomfort, Haemorrhage Subcutaneous, Supraventricular Tachycardia
on Aug 03, 2009 Male patient from , 70 years of age, was diagnosed with arrhythmia (What is arrhythmia?) and was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure, chest discomfort, haemorrhage subcutaneous, supraventricular tachycardia. Persantine dosage: . During the same period patient was treated with ARGAMATE (View Argamate Review and Argamate Label ), NORVASC (View Norvasc Review and Norvasc Label ), FRANDOL (View Frandol Review and Frandol Label ), OXAROL (View Oxarol Review and Oxarol Label ), VASOLAN (View Vasolan Review and Vasolan Label ), PHOSBLOCK (View Phosblock Review and Phosblock Label ), D SORBITOL (View D-sorbitol Review and D-sorbitol Label ), PHARLODINE (View Pharlodine Review and Pharlodine Label ).


6291803-X | Blood Creatine Increased, Product Deposit, Tubulointerstitial Nephritis
on Jul 28, 2009 Female patient from , weighting 127.9 lb, was diagnosed with cerebrovascular disorder, essential hypertension, diabetes mellitus and was treated with Persantine (View Usage). Patient had the following side effects: blood creatine increased, product deposit, tubulointerstitial nephritis. Persantine dosage: 400 Mg. During the same period patient was treated with KARVEZIDE (View Karvezide Review and Karvezide Label ), ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), AVANDAMET (View Avandamet Review and Avandamet Label ). Patient was hospitalized.

6284906-7 | Blood Creatine Increased, Product Deposit, Tubulointerstitial Nephritis
Patient was taking Persantine (View Usage). After Persantine was administered, patient had the following side effects: blood creatine increased, product deposit, tubulointerstitial nephritis on Jul 24, 2009 from Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with cerebrovascular disorder, essential hypertension, diabetes mellitus and. Persantine dosage: 400 Mg. During the same period patient was treated with KARVEZIDE (View Karvezide Review and Karvezide Label ), ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), AVANDAMET (View Avandamet Review and Avandamet Label ). Patient was hospitalized.

6274899-0 | Blood Creatine Increased, Product Deposit, Tubulointerstitial Nephritis
Adverse event was reported on Jul 15, 2009 by a Female patient taking Persantine (View Usage) (Dosage: 400 Mg) was diagnosed with cerebrovascular disorder, essential hypertension, diabetes mellitus and. Location: , weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: blood creatine increased, product deposit, tubulointerstitial nephritis. During the same period patient was treated with KARVEZIDE (View Karvezide Review and Karvezide Label ), ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), AVANDAMET (View Avandamet Review and Avandamet Label ). Patient was hospitalized.

6270749-7 | Anxiety, Granulocyte Count Decreased, Platelet Count Decreased, Restlessness, White Blood Cell Count Decreased
on Jul 10, 2009 Female patient from , weighting 165.3 lb, was diagnosed with glomerulonephritis chronic, hallucination, anxiety (What is anxiety?), insomnia and was treated with Persantine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), granulocyte count decreased, platelet count decreased, restlessness, white blood cell count decreased. Persantine dosage: 150 Mg. During the same period patient was treated with RISPERDAL (6 Mg) (View Risperdal Review and Risperdal Label ), LEXOTAN (6 Mg) (View Lexotan Review and Lexotan Label ), FLUTOPRAZEPAM (2 Mg) (View Flutoprazepam Review and Flutoprazepam Label ). Patient was hospitalized.

6258662-2 | Granulocyte Count Decreased, White Blood Cell Count Decreased
on Jul 06, 2009 Female patient from , 59 years of age, was treated with Persantine (View Usage). After Persantine was administered, patient had the following side effects: granulocyte count decreased, white blood cell count decreased. Persantine dosage: . Patient was hospitalized.

6240927-1 | Atrial Fibrillation, Cardiac Failure, Chest Discomfort, Haemorrhage Subcutaneous, Supraventricular Tachycardia
Patient was taking Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure, chest discomfort, haemorrhage subcutaneous, supraventricular tachycardia on Jun 18, 2009 from Additional patient health information: Male patient , 70 years of age, was diagnosed with arrhythmia (What is arrhythmia?) and. Persantine dosage: . During the same period patient was treated with ARGAMATE (View Argamate Review and Argamate Label ), NORVASC (View Norvasc Review and Norvasc Label ), FRANDOL (View Frandol Review and Frandol Label ), OXAROL (View Oxarol Review and Oxarol Label ), VASOLAN (View Vasolan Review and Vasolan Label ), PHOSBLOCK (View Phosblock Review and Phosblock Label ), D SORBITOL (View D-sorbitol Review and D-sorbitol Label ), PHARLODINE (View Pharlodine Review and Pharlodine Label ).

6223040-9 | Foetal Growth Retardation, Small For Dates Baby
Adverse event was reported on Jun 03, 2009 by a Female patient taking Persantine (View Usage) (Dosage: ) . Location: , weighting 5.42 lb, Patient had the following side effects: foetal growth retardation, small for dates baby.

6212950-4 | Aneurysm Ruptured, Cardiac Arrest, Cardiac Tamponade, Disease Progression
on May 29, 2009 Male patient from , child 5 years of age, was diagnosed with kawasaki's disease and was treated with Persantine (View Usage). After Persantine was administered, patient had the following side effects: aneurysm ruptured, cardiac arrest (What is cardiac arrest?), cardiac tamponade, disease progression. Persantine dosage: . During the same period patient was treated with ANGINAL (View Anginal Review and Anginal Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ULINASTATIN (View Ulinastatin Review and Ulinastatin Label ), HEPARIN (View Heparin Review and Heparin Label ), POLYGAM S/D (View Polygam S/d Review and Polygam S/d Label ).

6195333-5 | Haemolytic Anaemia
on May 18, 2009 Male patient from , 81 years of age, was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia. Persantine dosage: .

6181353-3 | Blood Pressure Decreased, Tinnitus
Patient was taking Persantine (View Usage). Patient had the following side effects: blood pressure decreased, tinnitus (What is tinnitus?) on Apr 28, 2009 from Additional patient health information: Male patient , weighting 200.6 lb, was diagnosed with scintigraphy and. Persantine dosage: Coated Tablets. During the same period patient was treated with MYOVIEW (600-700mbq) (View Myoview Review and Myoview Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), HJERTEMAGNYL (View Hjertemagnyl Review and Hjertemagnyl Label ).

6124947-3 | Granulocyte Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Mar 16, 2009 by a Female patient taking Persantine (View Usage) (Dosage: ) . Location: , 59 years of age, After Persantine was administered, patient had the following side effects: granulocyte count decreased, white blood cell count decreased. Patient was hospitalized.

6062029-X | Blood Creatinine Increased, Haemolysis, Thrombocytopenia, Thrombosis In Device
on Jan 29, 2009 Male patient from , 61 years of age, was diagnosed with thrombosis prophylaxis, thrombosis in device and was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, haemolysis, thrombocytopenia, thrombosis in device. Persantine dosage: 225mg. During the same period patient was treated with ASPIRIN (81mg) (View Aspirin Review and Aspirin Label ), WARFARIN SODIUM (4mg) (View Warfarin Sodium Review and Warfarin Sodium Label ), INTEGRILIN (2 Mcg/kg/min) (View Integrilin Review and Integrilin Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

5905287-1 | Spinal Haematoma
on Sep 25, 2008 Female patient from , 69 years of age, was diagnosed with glomerulonephritis rapidly progressive and was treated with Persantine (View Usage). Patient had the following side effects: spinal haematoma. Persantine dosage: 150mg. During the same period patient was treated with WARFARIN SODIUM (1mg) (View Warfarin Sodium Review and Warfarin Sodium Label ), PREDNISOLONE (40mg) (View Prednisolone Review and Prednisolone Label ).

5894023-3 | Hypoglycaemia
Patient was taking Persantine (View Usage). After Persantine was administered, patient had the following side effects: hypoglycaemia on Sep 19, 2008 from Additional patient health information: Female patient , child 2 years of age, . Persantine dosage: 25mg. During the same period patient was treated with EUGLUCON (2.5mg) (View Euglucon Review and Euglucon Label ), RENIVACE (5mg) (View Renivace Review and Renivace Label ), ASPIRIN (100mg) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5892069-2 | Spinal Haematoma
Adverse event was reported on Sep 17, 2008 by a Female patient taking Persantine (View Usage) (Dosage: 150mg) was diagnosed with glomerulonephritis rapidly progressive and. Location: , 69 years of age, Patient experienced the following unwanted or unexpected effects: spinal haematoma. During the same period patient was treated with WARFARIN SODIUM (1mg) (View Warfarin Sodium Review and Warfarin Sodium Label ), PREDNISOLONE (40mg) (View Prednisolone Review and Prednisolone Label ).

5869398-1 | Hypoglycaemia
on Aug 28, 2008 Female patient from JAPAN , child 2 years of age, was treated with Persantine (View Usage). Patient had the following side effects: hypoglycaemia. Persantine dosage: . During the same period patient was treated with EUGLUCON (View Euglucon Review and Euglucon Label ), RENIVACE (View Renivace Review and Renivace Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5844316-0 | Extradural Haematoma
on Aug 12, 2008 Female patient from , 88 years of age, weighting 94.80 lb, was treated with Persantine (View Usage). After Persantine was administered, patient had the following side effects: extradural haematoma. Persantine dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

5836797-3 | Convulsion, Hypoaesthesia, Movement Disorder, Waist Circumference Increased
Patient was taking Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hypoaesthesia, movement disorder (What is movement disorder?), waist circumference increased on Aug 06, 2008 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 190.0 lb, was diagnosed with cardiac stress test and. Persantine dosage: .

5827582-7 | Extradural Haematoma
Adverse event was reported on Jul 29, 2008 by a Female patient taking Persantine (View Usage) (Dosage: ) . Location: , 88 years of age, weighting 94.80 lb, Patient had the following side effects: extradural haematoma. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

5806549-9 | Alanine Aminotransferase Increased, Blood Amylase Increased, Dizziness, Haematemesis, Headache, Vomiting
on Jul 01, 2008 Male patient from , 56 years of age, was treated with Persantine (View Usage). After Persantine was administered, patient had the following side effects: alanine aminotransferase increased, blood amylase increased, dizziness (What is dizziness?), haematemesis, headache (What is headache?), vomiting. Persantine dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5722000-1 | Subdural Haematoma
on Apr 22, 2008 Male patient from FRANCE , 79 years of age, was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: subdural haematoma. Persantine dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ARTOTEC (View Artotec Review and Artotec Label ), STABLON (View Stablon Review and Stablon Label ). Patient was hospitalized.

5665063-4 | Pancytopenia
Patient was taking Persantine (View Usage). Patient had the following side effects: pancytopenia on Mar 07, 2008 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with stent placement and. Persantine dosage: .

5636019-2 | Bradycardia, Cardiac Arrest, Feeling Abnormal, Respiratory Arrest
Adverse event was reported on Feb 20, 2008 by a Female patient taking Persantine (View Usage) (Dosage: Once Iv) was diagnosed with cardiac stress test and. Location: UNITED STATES , weighting 166.7 lb, After Persantine was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), feeling abnormal, respiratory arrest.

5625130-8 | Asthenia, Nausea, Rash
on Jan 22, 2008 Male patient from UNITED STATES , 74 years of age, was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, nausea (What is nausea?), rash (What is rash?). Persantine dosage: .

5583983-6 | Malaise
on Jan 03, 2008 Male patient from UNITED STATES , 64 years of age, weighting 207.0 lb, was treated with Persantine (View Usage). Patient had the following side effects: malaise. Persantine dosage: .

5576635-X | Delirium
Patient was taking Persantine (View Usage). After Persantine was administered, patient had the following side effects: delirium on Dec 26, 2007 from JAPAN Additional patient health information: Male patient , 84 years of age, . Persantine dosage: Unk. During the same period patient was treated with DIOVAN (Unk) (View Diovan Review and Diovan Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ), SERMION (Unk) (View Sermion Review and Sermion Label ), ADALAT (Unk) (View Adalat Review and Adalat Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ).

5574737-5 | Chills, Tremor
Adverse event was reported on Dec 26, 2007 by a Male patient taking Persantine (View Usage) (Dosage: 42.8mg Over 4 Minutes Iv) was diagnosed with catheterisation cardiac and. Location: UNITED STATES , 61 years of age, weighting 180.0 lb, Patient experienced the following unwanted or unexpected effects: chills, tremor.

5567125-9 | Delirium
on Dec 10, 2007 Male patient from JAPAN , 84 years of age, was treated with Persantine (View Usage). Patient had the following side effects: delirium. Persantine dosage: Unk. During the same period patient was treated with DIOVAN (Unk) (View Diovan Review and Diovan Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ), SERMION (Unk) (View Sermion Review and Sermion Label ), ADALAT (Unk) (View Adalat Review and Adalat Label ).

5555905-5 | Back Pain, Inflammation, Pain In Extremity
on Dec 13, 2007 Female patient from UNITED STATES , weighting 100.1 lb, was diagnosed with cardiac stress test and was treated with Persantine (View Usage). After Persantine was administered, patient had the following side effects: back pain (What is back pain?), inflammation, pain in extremity. Persantine dosage: .

5538081-4 | Blood Pressure Increased, Erythema Of Eyelid, Eyelid Oedema, Lacrimation Increased, Scleral Discolouration, Tremor
Patient was taking Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, erythema of eyelid, eyelid oedema, lacrimation increased, scleral discolouration, tremor on Dec 04, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 179.9 lb, was diagnosed with blood pressure (What is blood pressure?) and. Persantine dosage: .

5538080-2 | Dysgeusia, Lip Swelling, Oedema Mouth, Oral Pruritus
Adverse event was reported on Dec 04, 2007 by a Female patient taking Persantine (View Usage) (Dosage: ) was diagnosed with cardiac stress test, chest pain (What is chest pain?) and. Location: UNITED STATES , weighting 158.0 lb, Patient had the following side effects: dysgeusia, lip swelling, oedema mouth, oral pruritus. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), CARDIOLITE (View Cardiolite Review and Cardiolite Label ).

5538076-0 | Application Site Irritation, Extravasation, Infusion Site Extravasation
on Dec 04, 2007 Female patient from UNITED STATES , weighting 273.0 lb, was diagnosed with cardiac stress test and was treated with Persantine (View Usage). After Persantine was administered, patient had the following side effects: application site irritation, extravasation, infusion site extravasation. Persantine dosage: .

5528445-7 | Oesophageal Haemorrhage
on Nov 21, 2007 Female patient from JAPAN , 69 years of age, weighting 116.8 lb, was diagnosed with nephritis and was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal haemorrhage. Persantine dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5226938-3 | Amnesia, Cardiac Arrest, Flushing, Nausea
Patient was taking Persantine (View Usage). Patient had the following side effects: amnesia, cardiac arrest (What is cardiac arrest?), flushing, nausea (What is nausea?) on Feb 01, 2007 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 115.0 lb, was diagnosed with heart rate irregular and. Persantine dosage: Iv.

5206300-X | Epistaxis, Thrombocytopenia
Adverse event was reported on Jan 04, 2007 by a Female patient taking Persantine (View Usage) (Dosage: ) was diagnosed with scintigraphy, hypertension, hypercholesterolaemia and. Location: FRANCE , 70 years of age, After Persantine was administered, patient had the following side effects: epistaxis, thrombocytopenia. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), EZETROL (View Ezetrol Review and Ezetrol Label ). Patient was hospitalized.

5075689-7 | Dizziness, Nausea
on Aug 03, 2006 Female patient from UNITED STATES , 65 years of age, weighting 212.0 lb, was diagnosed with cerebral infarction and was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), nausea (What is nausea?). Persantine dosage: Tid Po.

5075540-5 | Chest Pain
on Aug 03, 2006 Male patient from UNITED STATES , 73 years of age, weighting 211.9 lb, was treated with Persantine (View Usage). Patient had the following side effects: chest pain (What is chest pain?). Persantine dosage: . Patient was hospitalized.

5070185-5 | Blood Pressure Decreased
Patient was taking Persantine (View Usage). After Persantine was administered, patient had the following side effects: blood pressure decreased on Jul 21, 2006 from JAPAN Additional patient health information: Female patient , weighting 123.5 lb, was diagnosed with investigation and. Persantine dosage: . Patient was hospitalized.

5068982-5 | Blood Pressure Decreased
Adverse event was reported on Jul 21, 2006 by a Female patient taking Persantine (View Usage) (Dosage: ) was diagnosed with investigation and. Location: JAPAN , weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased. Patient was hospitalized.

5043469-4 | Bronchospasm, Coma, Infusion Related Reaction
on Mar 22, 2002 Male patient from , 49 years of age, was diagnosed with scintigraphy and was treated with Persantine (View Usage). Patient had the following side effects: bronchospasm, coma, infusion related reaction. Persantine dosage: . During the same period patient was treated with MAXAIR (View Maxair Review and Maxair Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), PROLAIR (View Prolair Review and Prolair Label ), THERALAIR (View Theralair Review and Theralair Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ). Patient was hospitalized.

5019852-X | Anoxia, Bronchospasm, Coma
on Mar 22, 2002 Male patient from , 49 years of age, was diagnosed with scintigraphy and was treated with Persantine (View Usage). After Persantine was administered, patient had the following side effects: anoxia, bronchospasm, coma. Persantine dosage: . During the same period patient was treated with MAXAIR (View Maxair Review and Maxair Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), PROLAIR (View Prolair Review and Prolair Label ), THERALAIR (View Theralair Review and Theralair Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ). Patient was hospitalized.

4970718-0 | Bradycardia, Hypotension, Nausea, Syncope
Patient was taking Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, hypotension, nausea (What is nausea?), syncope on Apr 11, 2006 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 140.0 lb, was diagnosed with cardiac stress test and. Persantine dosage: Intraven.

4920742-9 | Cardio-respiratory Arrest, Malaise, Syncope Vasovagal
Adverse event was reported on Sep 28, 2005 by a Male patient taking Persantine (View Usage) (Dosage: ) was diagnosed with scintigraphy and. Location: , 50 years of age, Patient had the following side effects: cardio-respiratory arrest, malaise, syncope vasovagal.

4875996-4 | Bradycardia, Hypotension
on Aug 12, 2005 Male patient from UNITED STATES , 67 years of age, was treated with Persantine (View Usage). After Persantine was administered, patient had the following side effects: bradycardia, hypotension. Persantine dosage: Iv. Patient was hospitalized.

4875995-2 | Headache, Nausea
on Feb 25, 2005 Male patient from UNITED STATES , 59 years of age, weighting 157.0 lb, was diagnosed with cardiac stress test and was treated with Persantine (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), nausea (What is nausea?). Persantine dosage: 40.2 Mg (see Text, 10mg/2ml).

4875994-0 | Dyspnoea
Patient was taking Persantine (View Usage). Patient had the following side effects: dyspnoea on Feb 25, 2005 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 207.0 lb, was diagnosed with cardiac stress test and. Persantine dosage: 52.7 Mg (see Text, 10 Mg / 2 Ml).